KALA BIO (KALA) Short Interest Ratio & Short Volume $3.77 -0.18 (-4.56%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$3.80 +0.03 (+0.90%) As of 05/21/2025 05:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KALA BIO Short Interest DataKALA BIO (KALA) has a short interest of 404,600 shares, representing 7.62% of the float (the number of shares available for trading by the public). This marks a 43.12% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.9, indicating that it would take 5.9 days of the average trading volume of 95,050 shares to cover all short positions.Current Short Interest404,600 sharesPrevious Short Interest282,700 sharesChange Vs. Previous Month+43.12%Dollar Volume Sold Short$1.61 millionShort Interest Ratio5.9 Days to CoverLast Record DateApril 30, 2025Outstanding Shares6,452,000 sharesFloat Size5,310,000 sharesShort Percent of Float7.62%Today's Trading Volume51,347 sharesAverage Trading Volume95,050 sharesToday's Volume Vs. Average54% Short Selling KALA BIO? Sign up to receive the latest short interest report for KALA BIO and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKALA Short Interest Over TimeKALA Days to Cover Over TimeKALA Percentage of Float Shorted Over Time KALA BIO Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025404,600 shares $1.61 million +43.1%7.6%5.9 $3.97 4/15/2025282,700 shares $997,931.00 +6.2%5.3%4.9 $3.53 3/31/2025266,100 shares $1.52 million -3.2%5.0%4.6 $5.73 3/15/2025274,800 shares $1.80 million -3.3%5.5%4.8 $6.55 2/28/2025284,200 shares $1.97 million -5.5%5.7%4.8 $6.93 2/15/2025300,700 shares $2.52 million +88.8%6.0%4.9 $8.38 1/31/2025159,300 shares $1.47 million +969.1%3.3%3.3 $9.20 1/15/202514,900 shares $106,237.00 -41.8%0.4%0.4 $7.13 12/31/202425,600 shares $177,664.00 +19.1%0.7%0.7 $6.94 12/15/202421,500 shares $132,870.00 -18.3%0.6%0.8 $6.18 Get the Latest News and Ratings for KALA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KALA BIO and its competitors with MarketBeat's FREE daily newsletter. 11/30/202426,300 shares $180,365.40 -13.8%0.7%1 $6.86 11/15/202430,500 shares $204,350.00 -18.7%0.8%1.4 $6.70 10/31/202437,500 shares $264,000.00 +28.0%1.0%2.1 $7.04 10/15/202429,300 shares $152,360.00 -2.0%0.8%2 $5.20 9/30/202429,900 shares $170,430.00 +38.4%0.8%1.5 $5.70 9/15/202421,600 shares $127,656.00 -4.9%0.6%0.1 $5.91 8/31/202422,700 shares $132,797.27 -27.0%0.6%0.1 $5.85 8/15/202431,100 shares $195,308.00 -30.1%0.9%0.1 $6.28 7/31/202444,500 shares $292,810.00 -32.4%1.2%0.2 $6.58 7/15/202465,800 shares $500,738.00 -77.7%3.0%0.3 $7.61 6/30/2024295,200 shares $2.09 million +2,086.7%12.8%1.3 $7.09 6/15/202413,500 shares $80,460.00 +75.3%0.6%0.7 $5.96 5/31/20247,700 shares $51,744.00 +28.3%0.3%0.4 $6.72 5/15/20246,000 shares $40,200.00 -31.8%0.3%0.3 $6.70 4/30/20248,800 shares $60,720.00 +72.6%0.4%0.5 $6.90 4/15/20245,100 shares $35,700.00 -15.0%0.2%0.2 $7.00 3/31/20246,000 shares $47,820.00 -50.4%0.3%0.2 $7.97 3/15/202412,100 shares $91,113.00 +22.2%0.5%0.4 $7.53 2/29/20249,900 shares $71,082.00 -18.2%0.4%0.2 $7.18 2/15/202412,100 shares $86,999.00 -28.4%0.5%0.1 $7.19 1/31/202416,900 shares $117,455.00 -50.2%0.8%0.2 $6.95 1/15/202433,900 shares $272,895.00 +20.2%1.6%0.4 $8.05 12/31/202328,200 shares $197,400.00 -61.6%1.4%0.4 $7.00 12/15/202373,500 shares $498,330.00 +34.9%3.4%1.1 $6.78 11/30/202354,500 shares $329,725.00 -14.0%2.6%0.8 $6.05 11/15/202363,400 shares $334,752.00 +0.2%3.0%3.6 $5.28 10/31/202363,300 shares $430,440.00 -15.8%3.2%3.3 $6.80 10/15/202375,200 shares $614,376.48 -24.8%3.8%3 $8.17 9/30/2023100,000 shares $890,000.00 +48.4%4.9%3.2 $8.90 9/15/202367,400 shares $716,462.00 +632.6%3.3%1.7 $10.63Warning: Prepare to Be Shocked by These Payouts (Ad)There's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don't even pay dividends. It's fast, it's legal, and most people have no clue it exists.Click here to see how much you could be collecting each month → 8/31/20239,200 shares $123,464.00 -87.8%0.5%0.2 $13.42 8/15/202375,500 shares $1.03 million -18.6%3.8%1.2 $13.70 7/31/202392,800 shares $1.39 million -51.0%4.6%1.2 $15.03 7/15/2023189,400 shares $2.73 million -0.7%10.2%2.2 $14.43 6/30/2023190,800 shares $2.78 million +34.0%10.3%1.6 $14.59 6/15/2023142,400 shares $2.10 million -4.9%7.8%1 $14.73 5/31/2023149,800 shares $2.14 million -20.1%7.5%0.7 $14.30 5/15/2023187,500 shares $3.13 million +12.6%9.4%0.3 $16.67 4/30/2023166,500 shares $2.63 million -3.1%10.0%0.3 $15.77 4/15/2023171,900 shares $2.86 million -32.9%10.4%0.2 $16.63 3/31/2023256,200 shares $3.86 million +29.5%15.4%0.3 $15.05 3/15/2023197,800 shares $3.30 million -20.6%12.4%0.1 $16.69 2/28/2023249,100 shares $2.52 million +16.6%18.5%0.1 $10.13 2/15/2023213,600 shares $2.73 million -29.6%15.4%0.1 $12.78 1/31/2023303,200 shares $5.26 million +28.3%22.6%0.1 $17.34 1/15/2023236,300 shares $4.64 million -52.2%17.6%0.1 $19.62 12/30/2022494,700 shares $18.87 million +389.3%38.4%0.2 $38.15 12/15/2022101,100 shares $442,818.00 +5.4%7.8%0.5 $4.38 11/30/202295,900 shares $507,311.00 +25.2%7.5%0.5 $5.29 11/15/202276,600 shares $491,772.00 +74.5%6.0%0.5 $6.42 10/31/202243,900 shares $278,765.00 +32.6%3.9%0.3 $6.35 10/15/202233,100 shares $415,405.00 -97.9%N/A1.2 $12.55 9/30/20221,610,000 shares $356,454.00 -13.0%2.7%1.6 $0.22 9/15/20221,850,000 shares $626,780.00 -11.9%3.1%1.4 $0.34 8/31/20222,100,000 shares $638,400.00 +1.9%3.5%1.4 $0.30 8/15/20222,060,000 shares $683,302.00 +13.2%3.4%1.1 $0.33 7/31/20221,820,000 shares $600,600.00 -11.2%3.1%1.1 $0.33 7/15/20222,050,000 shares $696,795.00 -5.1%3.4%1.2 $0.34 6/30/20222,160,000 shares $648,000.00 -38.8%3.6%1.2 $0.30 6/15/20223,530,000 shares $1.37 million -29.4%5.9%2.1 $0.39 5/31/20225,000,000 shares $1.74 million -4.6%8.4%2.3 $0.35 5/15/20225,240,000 shares $3.58 million +15.9%8.8%2.3 $0.68 4/30/20224,520,000 shares $2.94 million +1.6%7.6%2.3 $0.65 4/15/20224,450,000 shares $3.79 million -11.5%7.5%2.4 $0.85 3/31/20225,030,000 shares $6.94 million -30.1%8.6%2.6 $1.38 3/15/20227,200,000 shares $13.18 million +76.5%13.7%3.7 $1.83 2/28/20224,080,000 shares $2.70 million -2.4%7.8%3.1 $0.66 2/15/20224,180,000 shares $3.22 million +6.4%8.0%4.5 $0.77 1/31/20223,930,000 shares $3.48 million +7.7%7.5%3.6 $0.89 1/15/20223,650,000 shares $3.80 million -13.7%7.0%2.9 $1.04 12/31/20214,230,000 shares $5.12 million -17.9%8.1%2.8 $1.21 12/15/20215,150,000 shares $7.42 million -27.5%9.8%3.5 $1.44 11/30/20217,100,000 shares $13.49 million -16.2%13.5%5 $1.90 11/15/20218,470,000 shares $17.79 million -0.5%16.3%5.9 $2.10 10/29/20218,510,000 shares $14.81 million -3.3%14.8%6.5 $1.74 10/15/20218,800,000 shares $19.45 million -4.1%16.9%6.9 $2.21 9/30/20219,180,000 shares $24.05 million +12.5%17.6%7.7 $2.62 9/15/20218,160,000 shares $25.13 million -15.8%15.7%5.6 $3.08 8/31/20219,690,000 shares $32.75 million +13.9%18.6%6.1 $3.38 8/13/20218,510,000 shares $25.79 million -4.6%16.6%4.6 $3.03Trump’s treachery (Ad)I think Trump’s Treasury Secretary is destroying the stock market on purpose. And no one on Wall Street seems to understand why. Like an addict who needs desperate help, Trump’s Treasury pick, Scott Bessent, is putting America through a “detox period” — and I think it’s going to be absolutely brutal for our economy. Why’s he doing this?You may have already noticed the effect on your portfolio as markets have begun to bleed. 7/30/20218,920,000 shares $30.77 million +5.4%17.5%4.2 $3.45 7/15/20218,460,000 shares $33.92 million -0.8%15.0%3.6 $4.01 6/30/20218,530,000 shares $45.21 million +6.0%15.1%3.7 $5.30 6/15/20218,050,000 shares $45.89 million +3.2%14.2%3.5 $5.70 5/28/20217,800,000 shares $44.07 million -4.4%13.8%3.3 $5.65 5/14/20218,160,000 shares $41.53 million -15.5%N/A3.4 $5.09 4/30/20219,660,000 shares $75.83 million -3.2%N/A4 $7.85 4/15/20219,980,000 shares $71.96 million -14.9%N/A4.4 $7.21 3/31/202111,720,000 shares $75.01 million +5.5%N/A4.9 $6.40 3/15/202111,110,000 shares $85.10 million +4.9%N/A4.7 $7.66 2/26/202110,590,000 shares $81.91 million +13.4%N/A4.7 $7.74 2/12/20219,340,000 shares $82.01 million -1.4%N/A4.6 $8.78 1/29/20219,470,000 shares $71.88 million +6.2%N/A5 $7.59 1/15/20218,920,000 shares $66.99 million -5.5%N/A4.6 $7.51 12/31/20209,440,000 shares $64.95 million +16.4%N/A5.4 $6.88 12/15/20208,110,000 shares $61.96 million +19.1%N/A5 $7.64 11/30/20206,810,000 shares $49.71 million -2.3%N/A4.5 $7.30 11/15/20206,970,000 shares $51.72 million -15.3%N/A5 $7.42 10/30/20208,230,000 shares $57.36 million +34.7%N/A6.2 $6.97 10/15/20206,110,000 shares $49.80 million -6.4%N/A5.7 $8.15 9/30/20206,530,000 shares $48.98 million +6.0%N/A6.4 $7.50 9/15/20206,160,000 shares $49.59 million +6.2%N/A6.4 $8.05 8/31/20205,800,000 shares $51.62 million +35.2%N/A6.5 $8.90 8/14/20204,290,000 shares $37.62 million -20.7%N/A4.5 $8.77 7/31/20205,410,000 shares $47.34 million +1.3%N/A5.7 $8.75 7/15/20205,340,000 shares $54.84 million +2.9%N/A5.2 $10.27 6/30/20205,190,000 shares $54.55 million +44.2%N/A4.9 $10.51 6/15/20203,600,000 shares $46.66 million -3.7%N/A3.1 $12.96 5/29/20203,740,000 shares $46.04 million -6.0%N/A2.4 $12.31 KALA Short Interest - Frequently Asked Questions What is KALA BIO's current short interest? Short interest is the volume of KALA BIO shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 404,600 shares of KALA short. 7.62% of KALA BIO's shares are currently sold short. Learn More on KALA BIO's current short interest. What is a good short interest ratio for KALA BIO? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KALA shares currently have a short interest ratio of 6.0. Learn More on KALA BIO's short interest ratio. What is a good short interest percentage for KALA BIO? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.62% of KALA BIO's floating shares are currently sold short. Is KALA BIO's short interest increasing or decreasing? KALA BIO saw a increase in short interest in April. As of April 30th, there was short interest totaling 404,600 shares, an increase of 43.1% from the previous total of 282,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is KALA BIO's float size? KALA BIO currently has issued a total of 6,452,000 shares. Some of KALA BIO's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. KALA BIO currently has a public float of 5,310,000 shares. How does KALA BIO's short interest compare to its competitors? 7.62% of KALA BIO's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to KALA BIO: Galectin Therapeutics Inc. (19.42%), Corbus Pharmaceuticals Holdings, Inc. (17.54%), Lexeo Therapeutics, Inc. (13.02%), Ventyx Biosciences, Inc. (11.55%), Anixa Biosciences, Inc. (1.17%), Senti Biosciences, Inc. (3.18%), Zura Bio Limited (5.94%), Cellectis S.A. (0.57%), OncoCyte Co. (1.63%), Adagene Inc. (0.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short KALA BIO stock? Short selling KALA is an investing strategy that aims to generate trading profit from KALA BIO as its price is falling. KALA shares are trading down $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against KALA BIO? A short squeeze for KALA BIO occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KALA, which in turn drives the price of the stock up even further. How often is KALA BIO's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KALA, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Galectin Therapeutics Short Squeeze Corbus Pharmaceuticals Short Squeeze Lexeo Therapeutics Short Squeeze Ventyx Biosciences Short Squeeze Anixa Biosciences Short Squeeze Senti Biosciences Short Squeeze Zura Bio Short Squeeze Cellectis Short Squeeze OncoCyte Short Squeeze Adagene Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KALA) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KALA BIO, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share KALA BIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KALA Stock Free KALA Stock Alerts